Sorrento Therapeutics market cap is $2.6 b, and annual revenue was $31.43 m in FY 2019

Sorrento Therapeutics Net income (Q2, 2020)-85 M

Sorrento Therapeutics EBIT (Q2, 2020)-47.7 M

Sorrento Therapeutics Cash, 30-Jun-202024.4 M

Sorrento Therapeutics EV2.8 B

USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 |
---|---|---|---|---|---|---|---|---|---|

## Revenue | 529.2k | 583.8k | 460.1k | 3.8m | 4.6m | 8.2m | 151.9m | 21.2m | 31.4m |

| 731% | 20% | 78% | ||||||

## Cost of goods sold | 4.4k | 2.0m | 2.0m | 811.0k | 3.9m | 7.1m | |||

## Gross profit | 455.7k | 1.8m | 2.6m | 7.3m | 147.9m | 14.1m | |||

| 99% | 47% | 58% | 90% | 97% | 67% | |||

## R&D expense | 2.6m | 3.8m | 9.0m | 24.0m | 24.0m | 45.0m | 26.1m | 11.3m | 106.9m |

## General and administrative expense | 1.2m | 1.6m | 6.3m | 10.0m | 20.1m | 24.2m | 38.3m | 63.6m | 103.6m |

## Operating expense total | 3.8m | 5.4m | 22.1m | 36.5m | 76.6m | 104.1m | 122.6m | 164.6m | 210.4m |

## EBIT | (3.2m) | (4.9m) | (21.7m) | (34.7m) | (74.0m) | (96.8m) | 25.3m | (150.4m) | (259.4m) |

| (613%) | (831%) | (4709%) | (908%) | (1612%) | (1187%) | 17% | (710%) | (825%) |

## Interest income | 6.0k | 7.3k | 9.6k | 12.0k | 24.0k | 272.0k | 241.0k | 921.0k | 1.1m |

## Investment income | (4.0m) | 435.0k | (40.2m) | (5.0m) | (3.9m) | ||||

## Pre tax profit | (36.4m) | (13.8m) | (64.8m) | 15.3m | (213.8m) | (359.6m) | |||

## Income tax expense | (1.7m) | 36.3m | (896.0k) | (36.0m) | (6.3m) | (473.0k) | |||

## Net Income | (3.2m) | (4.8m) | (21.9m) | (34.7m) | (45.8m) | (60.9m) | 9.1m | (203.5m) | (363.0m) |

USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 |
---|---|---|---|---|---|---|---|---|

## Cash | 3.5m | 5.1m | 31.7m | 71.9m | 39.0m | 82.4m | 20.4m | 158.7m |

## Accounts Receivable | 2.2m | 3.8m | ||||||

## Prepaid Expenses | 29.9k | 80.9k | 4.9m | 6.6m | ||||

## Current Assets | 3.6m | 5.3m | 32.6m | 73.9m | 141.0m | 89.7m | 29.7m | 179.6m |

## PP&E | 988.4k | 1.5m | 2.4m | 2.3m | 7.2m | 12.7m | 19.3m | 24.4m |

## Goodwill | 24.0m | 24.0m | 20.6m | 41.5m | 38.3m | 38.3m | ||

## Total Assets | 4.6m | 6.8m | 92.6m | 141.5m | 343.5m | 401.6m | 431.6m | 624.1m |

## Accounts Payable | 224.7k | 439.5k | 2.2m | 1.7m | 1.3m | 8.3m | 9.9m | 13.8m |

## Short-term debt | 194.6k | 10.2m | ||||||

## Current Liabilities | 359.3k | 584.2k | 5.5m | 9.6m | 30.9m | 76.1m | 79.0m | 61.6m |

## Long-term debt | 875.9k | 4.4m | 8.8m | 4.4m | 47.1m | 5.2m | 223.1m | |

## Total Debt | 1.1m | 47.1m | 5.2m | 233.3m | ||||

## Total Liabilities | 315.1m | 225.0m | 416.6m | |||||

## Common Stock | 26.2k | 30.0k | 9.0k | 13.0k | ||||

## Preferred Stock | ||||||||

## Additional Paid-in Capital | 10.3m | 17.1m | 99.7m | 176.2m | 184.9m | 303.9m | 413.9m | 626.7m |

## Retained Earnings | (67.5m) | (113.3m) | (174.3m) | (165.1m) | (367.7m) | |||

## Total Equity | 4.2m | 6.2m | 66.8m | 108.7m | 140.9m | 86.5m | 206.6m | 207.5m |

## Debt to Equity Ratio | 0.2 x | 0.5 x | ||||||

## Debt to Assets Ratio | 0.2 x | 0.1 x | ||||||

## Financial Leverage | 1.1 x | 1.1 x | 1.4 x | 1.3 x | 2.4 x | 4.6 x | 2.1 x | 3 x |

USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 |
---|---|---|---|---|---|---|---|---|---|

## Net Income | (3.2m) | (4.8m) | (21.9m) | (34.7m) | (50.1m) | (63.9m) | 11.1m | (212.5m) | (363.0m) |

## Depreciation and Amortization | 159.2k | 293.3k | 1.3m | 3.2m | 2.4m | 2.9m | 7.1m | 9.1m | 11.0m |

## Accounts Receivable | 184.8k | (18.5k) | (2.2m) | (515.0k) | (1.6m) | (10.6m) | |||

## Inventories | (3.2m) | ||||||||

## Accounts Payable | 42.9k | (23.2k) | 878.6k | (497.0k) | (2.7m) | 3.7m | 1.6m | 3.6m | 10.2m |

## Cash From Operating Activities | (2.7m) | (3.8m) | (16.5m) | (28.8m) | (42.1m) | (70.9m) | (99.2m) | (111.8m) | (173.0m) |

## Purchases of PP&E | (1.1m) | (547.9k) | (420.2k) | (591.0k) | (3.7m) | (6.9m) | (11.0m) | (11.2m) | (11.4m) |

## Cash From Investing Activities | (1.1m) | (547.9k) | (503.5k) | (10.6m) | 12.6m | (17.5m) | (16.5m) | (21.2m) | (38.2m) |

## Short-term Borrowings | (20.0m) | ||||||||

## Long-term Borrowings | (53.2m) | (3.1m) | |||||||

## Cash From Financing Activities | 2.0m | 6.0m | 43.6m | 79.6m | (3.3m) | 131.7m | 53.7m | 326.0m | 78.9m |

## Net Change in Cash | (1.8m) | 1.6m | (62.0m) | 193.0m | (132.3m) | ||||

## Interest Paid | 1.5m | 1.6m | 1.3m | 3.5m | 1.6m | 12.7m | |||

## Income Taxes Paid | 800.0 | 800.0 | 800.0 | 6.0k | 3.0m | 2.0k | 34.0k | 6.0k | 13.0k |

USD | Q2, 2011 |
---|---|

## Financial Leverage | 1.1 x |